Related Experiment Video
Updated: Nov 7, 2025

08:25
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
Published on: September 9, 2020
11.4K
Personalising care in oesophageal cancer care with liquid biopsy
Bruno De Paula1, Elizabeth C Smyth2
1Department of Oncology, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
British Journal of Cancer
|May 1, 2021
Abstract:
The advent of ctDNA has the potential to be a game changer in some cancers, but limited data is available in oesophago-gastric cancers (OGC). The prognostic value of ctDNA and the potential for false positive results due to clonal haematopoiesis of indeterminate potential (CHIP) was recently reported in operable OGC.

